Oura publicly files for initial public offering, looks to raise $2.2 billion

Oura, a health tracking ring maker, filed for an IPO aiming to raise $2.2B by selling 50M shares at $40-$44 each, listing on Nasdaq as OURA. The company reported $1.2B revenue for the nine months ending June 30, up from $697M last year, with a net loss of $924M. It sold 4.1M rings and has 5M paid subscription members.

Original reporting
Published Sep 21, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 3:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Oura publicly files for initial public offering, looks to raise $2.2 billion — source image
Decision brief

The 30-second read

High
01

Why it matters

The filing introduces a sizable new IPO in the consumer‑tech space, offering investors exposure to a niche wearables market with strong subscription revenue growth.

02

Market read

The IPO could attract both growth‑oriented investors and those seeking exposure to health‑data platforms, influencing wearables sector dynamics.

03

What to watch

Regulatory scrutiny of health data privacy and subscription churn could affect long‑term profitability.

Relevance 9/10Novelty 9/10Timing: IPO filing announced today

Background

Oura, a Finnish maker of health‑tracking rings, filed its S‑1 to list on Nasdaq under the ticker OURA, seeking to raise up to $2.2 billion.

Market effects

Adds a new public player to the health‑tracking wearables sector, increasing competition for Fitbit and Apple.

Highlights Finnish tech's move into US capital markets, may boost Nordic tech sentiment.

Potentially broadens investor exposure to consumer health data platforms worldwide.

Counterpoint

The IPO may be over‑hyped; valuation could be stretched given ongoing net losses.

Key entities

  • Oura

    Finnish health‑tracking ring manufacturer planning Nasdaq IPO.

Related articles

$COINMedAI 8/10

Coinbase Opens IPO Access — Oura Is First, But There's a Catch

Coinbase launched a new service allowing eligible U.S. retail customers to request allocations in IPOs, starting with Oura's $2.2B IPO. Oura plans to sell 13.5M shares at $40-$44 each, with a fully diluted valuation of about $15.62B. Coinbase's IPO access prioritizes long-term investors, discouraging early selling.

$OURAHighAI 9/10

Smart ring maker Oura targets $2.2 billion in US listing

Oura Inc, a smart ring maker, aims to raise $2.2B in a US IPO, offering 50M shares at $40-$44 each. The company could be valued at $14.1B-$15B. Oura reported a $924.3M net loss on $1.21B revenue for the nine months ended June 30. The IPO is expected to price on September 29, with shares trading on Nasdaq under ticker OURA.

$COINHigh

Coinbase IPO News: US Retail Access Opens, With Oura Up First

Coinbase launched a feature allowing eligible US retail customers to request IPO shares, starting with Oura. Oura plans to offer 13.5M shares priced between $40 and $44, listing on Nasdaq as OURA. Coinbase's stock (COIN) rose 3.5% to $201.05 on the news, with a market cap of $53.04B. Oura's IPO is expected to price this week.

$OURAHighAI 9/10

Oura smart ring IPO roadshow launches, targets $2.2 billion

Oura Health launched its IPO, aiming to raise $2.2B by selling 50M shares at $40-$44 each, targeting a $15.62B valuation. Trading under 'OURA' on Nasdaq, it sold 3.6M rings in the past year with $1.21B revenue. Eli Lilly and Dragoneer may invest $100M and $300M respectively. The company faces a lawsuit over sleep tracking accuracy claims.